CNBX Pharmaceuticals Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • CNBX Pharmaceuticals Inc. Return On Equity for the quarter ending August 31, 2024 was 29.6 %, a 84.2% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual Return On Equity for 2024 was 29.6 %, a 84.2% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual Return On Equity for 2023 was 188 %.
  • CNBX Pharmaceuticals Inc. annual Return On Equity for 2022 was -2.46K %, a 1669% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 29.6 -158 -84.2% Jun 1, 2024 Aug 31, 2024
Q2 2024 54.2 -285 -84% Mar 1, 2024 May 31, 2024
Q1 2024 58.8 -410 -87.5% Dec 1, 2023 Feb 29, 2024
Q4 2023 176 -332 -65.4% Sep 1, 2023 Nov 30, 2023
Q3 2023 188 +2.65K Jun 1, 2023 Aug 31, 2023
Q2 2023 339 +2.36K Mar 1, 2023 May 31, 2023
Q1 2023 469 +894 Dec 1, 2022 Feb 28, 2023
Q4 2022 508 +685 Sep 1, 2022 Nov 30, 2022
Q3 2022 -2.46K -2.32K -1669% Jun 1, 2022 Aug 31, 2022
Q2 2022 -2.02K -1.88K -1320% Mar 1, 2022 May 31, 2022
Q1 2022 -426 -312 -274% Dec 1, 2021 Feb 28, 2022
Q4 2021 -177 -39.3 -28.5% Sep 1, 2021 Nov 30, 2021
Q3 2021 -139 +82.8 +37.3% Jun 1, 2021 Aug 31, 2021
Q2 2021 -142 -19.1 -15.5% Mar 1, 2021 May 31, 2021
Q1 2021 -114 -40.1 -54.5% Dec 1, 2020 Feb 28, 2021
Q4 2020 -138 -115 -497% Sep 1, 2020 Nov 30, 2020
Q3 2020 -222 -229 -3094% Jun 1, 2020 Aug 31, 2020
Q2 2020 -123 -138 -940% Mar 1, 2020 May 31, 2020
Q1 2020 -73.6 -91.7 -504% Dec 1, 2019 Feb 29, 2020
Q4 2019 -23.1 +65.4 +73.9% Sep 1, 2019 Nov 30, 2019
Q3 2019 7.42 +145 Jun 1, 2019 Aug 31, 2019
Q2 2019 14.6 +324 Mar 1, 2019 May 31, 2019
Q1 2019 18.2 +269 Dec 1, 2018 Feb 28, 2019
Q4 2018 -88.5 +338 +79.2% Sep 1, 2018 Nov 30, 2018
Q3 2018 -138 -1.78K -108% Jun 1, 2018 Aug 31, 2018
Q2 2018 -309 -127 -70% Mar 1, 2018 May 31, 2018
Q1 2018 -251 -468 -216% Dec 1, 2017 Feb 28, 2018
Q4 2017 -426 -533 -499% Sep 1, 2017 Nov 30, 2017
Q3 2017 1.64K +1.57K +2019% Jun 1, 2017 Aug 31, 2017
Q2 2017 -182 -303 -250% Mar 1, 2017 May 31, 2017
Q1 2017 217 +29.8 +15.9% Dec 1, 2016 Feb 28, 2017
Q4 2016 107 -114 -51.7% Sep 1, 2016 Nov 30, 2016
Q3 2016 77.6 -1.73K -95.7% Jun 1, 2016 Aug 31, 2016
Q2 2016 122 +1K Mar 1, 2016 May 31, 2016
Q1 2016 187 +595 Dec 1, 2015 Feb 29, 2016
Q4 2015 221 +609 Sep 1, 2015 Nov 30, 2015
Q3 2015 1.81K -1.53K -45.9% Jun 1, 2015 Aug 31, 2015
Q2 2015 -880 -1.18K -393% Mar 1, 2015 May 31, 2015
Q1 2015 -408 -541 -407% Dec 1, 2014 Feb 28, 2015
Q4 2014 -388 -470 -573% Sep 1, 2014 Nov 30, 2014
Q3 2014 3.34K +3.26K +4510% Jun 1, 2014 Aug 31, 2014
Q2 2014 300 +284 +1805% Mar 1, 2014 May 31, 2014
Q1 2014 133 Dec 1, 2013 Feb 28, 2014
Q4 2013 82 Sep 1, 2013 Nov 30, 2013
Q3 2013 72.4 Jun 1, 2013 Aug 31, 2013
Q2 2013 15.7 Mar 1, 2013 May 31, 2013
Q1 2012 199 Dec 1, 2011 Feb 29, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.